Artículos científicos Open Access
COVID-19 and fungal infection: the need for a strategic approach
The Lancet Microbe
P Lewis White, Rishi Dhillon, Harriet Hughes, Matthew P Wise, Matthijs Backx
Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access
The Lancet
Alexandra L Phelan, Mark Eccleston-Turner, Michelle Rourke, Allan Maleche, Chenguang Wang
Multisystem inflammatory syndrome in children: A systematic review
EClinicalMedicine
Mubbasheer Ahmed, Shailesh Advani, Axel Moreira, Sarah Zoretic, John Martinez, Kevin Chorath, and others
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
The Lancet
Denis Y Logunov, Inna V Dolzhikova, Olga V Zubkova, Amir I Tukhvatullin, Dmitry V Shcheblyakov, Alina S Dzharullaeva, and others
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
The Lancet Rheumatology
Philip C Robinson, Duncan Richards, Helen L Tanner, Marc Feldmann
Mavrilimumab for severe COVID-19
The Lancet Rheumatology
Mohamad Amin Pourhoseingholi, Sajad Shojaee, Sara Ashtari
The US politicisation of the pandemic: Raul Grijalva on masks, BAME, and covid-19
The BMJ
Paul D Thacker
